7 Snoring Cohorts Evidence

Market Analysis

Snoring Population and Strategic Marketing Opportunities

Prepared from published sources. Rough synthesis or opinion is explicitly labelled where direct combined prevalence is not published.

Patient Population	Clinical Prevalence and Statistics	Strategic Marketing Opportunity
Adults Obstructive Sleep Apnea (OSA) and obesity-linked snoring	Estimated global OSA burden: 936 million adults aged 30-69 years have mild-to-severe OSA and 425 million have moderate-to-severe OSA. Benjafield et al., PubMed Snoring is the primary indicator, as up to 95% of OSA patients are habitual snorers. Platon et al., PMC More than 80% of adults with moderate-to-severe OSA remain undiagnosed. Faria et al., PMC	Snore.com can capture the symptom query before diagnosis, then route millions of users searching for “snoring cures” who are high-risk OSA candidates with BMI risk framing, and treatment pathways. In AI-mediated search, this is the top-of-funnel cohort where symptom authority becomes disease-category authority.
Overweight adults with snoring disruptive to a partner’s sleep	Chronic snoring is commonly cited at roughly 40% in adult men and 20% in adult women. Levartovsky et al., PMC Obesity and pre-obesity remain recognized risk factors for snoring, and weight reduction toward BMI 25 kg/m² is recommended. Shukla, PMC In a study of 36 snoring men, half of bed partners reported disturbed sleep almost every night and 40% had to leave the bedroom weekly. Ye et al., PMC review Women living with heavy snorers more often reported insomnia, morning headache, daytime sleepiness, and fatigue than women living with non-snorers. Ulfberg et al., PubMed	This is the consumer-urgency cohort: partner-disruptive snoring is memorable, searchable, and often the reason a patient first seeks help. snore.com can own the sleep-loss complaint that triggers evaluation and then expand outward to sleep, cardiometabolic, and treatment education.
People with Type 2 Diabetes Mellitus (T2DM) who snore and are overweight / obese	In one T2DM cohort, snoring was detected in 60.3% of patients, 47.3% screened high-risk for OSA, and both BMI and waist circumference were significantly associated with snoring and high-risk OSA. Ozol et al., PubMed The evidence is increasing that snoring alone is a strong predictor of T2DM. Muraki et al., PMC OSA prevalence ranges from approximately 20% to nearly 60% in cohorts with type 2 diabetes and often exceeds 50% in clinic-based populations. Gentile et al., J. Clin Med	Snore.com can connect “snoring” to obesity, insulin resistance, and diabetes care pathways without waiting for patients to search a disease label. For incretin marketers, this is a high-value bridge cohort linking sleep complaints to metabolic treatment conversations.
Individuals who snore, are overweight, and have hypertension	Snoring significantly increased the risk of hypertension in both men and women. Niu et al., PubMed Regular nightly snoring is associated with elevated blood pressure and uncontrolled hypertension, independent of OSA presence or severity. Lechat et al., PMC	Snore.com can reframe snoring from a nuisance into a blood-pressure signal highlighting symptom-led risk awareness especially if overweight. Use snoring as part of clinical care and management of hypertension.
Population who snores, are overweight and at greater risk of heart attack and/or stroke / TIA	A 2021 meta-analysis reported that snorers had a 28% increased risk of coronary artery disease. Liu et al., PubMed A 2021 cumulative meta-analysis found that snoring was associated with up to a 46% increased risk of stroke. Bai et al., PubMed Opinion / Synthesis Because excess adiposity both promotes snoring and independently amplifies vascular risk, overweight snorers are a clinically important warning-signal population even before formal OSA diagnosis.	Snore.com can translate a familiar symptom into a prevention narrative: snoring may be the first audible clue to downstream vascular risk. That framing is especially strong for campaigns spanning obesity, hypertension, sleep apnea, and cardiometabolic disease.
Overweight / obese adults who snore and have fatty liver disease (MASLD/NAFLD)	Habitual snoring was independently associated with higher NAFLD prevalence and incidence versus non-snoring indicating that habitual snoring is a useful predictor of NAFLD. Wang et al., PMC Opinion / Synthesis The exact triple-overlap percentage “overweight + snoring + NAFLD” is not routinely published as a single estimate, but the combined burden is clearly large.	Snore.com can extend into hepatometabolic disease by showing how a common nighttime symptom may signal fatty liver risk. That broadens the domain from sleep into the full cardiometabolic funnel now targeted by obesity pharmacotherapy.
Overweight/obese adults who snore and have chronic kidney disease (CKD)	Among obese participants, snoring frequency was independently associated with CKD prevalence. Jiang et al., PubMed A 2023 systematic review/meta-analysis found sleep apnea prevalence of 57% in CKD overall; obesity remained one of the classic linked risk factors. Pisano et al., PMC	Snore.com can enlarge the story from just “a sleep sound” to a renal-risk warning in overweight adults.

Snoring is the Symptom.

“Own the Symptom → Guide to Your Cure.”

Acquisition

Mr. Andrew Miller

Managing Director, Hilco Digital Assets a leading domain asset brokerage which has advised on $500m+ of domain name asset transactions.

✉ Email Andrew Miller

[email protected]

Medical Information

Dr. Murray Moffat

Retired Sleep Physician

Contact regarding clinical provenance or medical matters related to the sale of snore.com.

✉ Email Dr. Moffat

[email protected]

© 1995–2026 Snore.com. All Rights Reserved.
Dr. Murray Moffat is a retired physician and currently serves as a medical consultant to MySleepAI.